GBT

Global Blood Therapeutics (GBT)

Global Blood Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GBT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/10	01 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/17	21 : 34	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 41	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 33	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 28	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 22	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/05	22 : 00	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/05	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc